We are live on ! Find out more
NGNE icon

Neurogene
NGNE

45 hedge funds and large institutions have $8.66M invested in Neurogene in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.2% less ownership

Funds ownership: 2.2% → 2% (-0.2%)

13% less funds holding

Funds holding: 52 → 45 (-7)

28% less capital invested

Capital invested by funds: $12M → $8.66M (-$3.32M)

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

60% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 15

Holders
45
Holders Change
-7
Holders Change %
-13.46%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
15
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LCM
Lynx1 Capital Management
Puerto Rico
+$1.18M
2
Bank of America
Bank of America
North Carolina
+$748K
3
Jane Street
Jane Street
New York
+$31.3K
4
HighTower Advisors
HighTower Advisors
Illinois
+$25K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$13.7K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$995K
2
RG
Redmile Group
California
-$819K
3
OM
Opaleye Management
Massachusetts
-$368K
4
BlackRock
BlackRock
New York
-$142K
5
Renaissance Technologies
Renaissance Technologies
New York
-$128K
Name Holding Trade Value Shares
Change 		Change in
Stake
E
26
Ergoteles
New York
$12.2K -$65.7K -6,364 -84%
UBS Group
27
UBS Group
Switzerland
$11.1K +$3.76K +364 +50%
US Bancorp
28
US Bancorp
Minnesota
$10.7K – – –
Acadian Asset Management
29
Acadian Asset Management
Massachusetts
$10K – – –
Janney Montgomery Scott
30
Janney Montgomery Scott
Pennsylvania
$10K – – –
EWM
31
Endurance Wealth Management
Rhode Island
$10K +$5.16K +500 +100%
Nomura Holdings
32
Nomura Holdings
Japan
$8K – – –
Bank of New York Mellon
33
Bank of New York Mellon
New York
$7.32K – – –
KAS
34
Kestra Advisory Services
Texas
$6.79K +$6.89K +667 New
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
$5.43K +$5.4K +523 New
TLP
36
Tri Locum Partners
New York
$5K +$5.29K +512 New
Wells Fargo
37
Wells Fargo
California
$4.19K – – –
Federated Hermes
38
Federated Hermes
Pennsylvania
$2.29K +$103 +10 +5%
TRCT
39
Tower Research Capital (TRC)
New York
$2K -$3.21K -311 -62%
Group One Trading
40
Group One Trading
Illinois
$1.02K – – –
Osaic Holdings
41
Osaic Holdings
Arizona
$1K – – –
TC
42
Truvestments Capital
Florida
$471 – – –
Citigroup
43
Citigroup
New York
$137 -$258 -25 -64%
CSS
44
Cubist Systematic Strategies
Connecticut
$5 -$3.16K -306 Closed
Dimensional Fund Advisors
45
Dimensional Fund Advisors
Texas
$5 – – –
OM
46
Opaleye Management
Massachusetts
– -$368K -28,750 Closed
RA
47
Royce & Associates
New York
– -$93K -7,270 Closed
RWP
48
RWA Wealth Partners
Massachusetts
– -$34K -2,691 Closed
HPWM
49
Highland Private Wealth Management
Washington
– -$30K -2,350 Closed
Qube Research & Technologies (QRT)
50
Qube Research & Technologies (QRT)
United Kingdom
– -$16K -1,219 Closed
1
2
3

NGNE Hedge Fund Activity: Q4 2022 in Review

45 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q4 2022, worth a combined $8.66M — down 28% from $12M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of NGNE and 7 opened new positions — a net loss of 6 holders — while 15 trimmed existing stakes and 6 added.

The largest buyer was Lynx1 Capital Management, opening a new position worth an estimated $1.18M. The largest seller was Point72 Asset Management, cutting an estimated $995K.

  • 45 institutional investors held Neurogene (NGNE) as of Q4 2022, down from 52 in Q3 2022.
  • Funds reported $8.66M of Neurogene stock for Q4 2022, down 28% quarter-over-quarter.
  • 7 funds opened new Neurogene positions in Q4 2022 and 13 closed out, a net change of -6 holders.
  • The largest Neurogene buyer in Q4 2022 was Lynx1 Capital Management, an estimated $1.18M added.
  • The largest Neurogene seller in Q4 2022 was Point72 Asset Management, an estimated $995K sold.

Based on aggregated 13F filings for Q4 2022.